Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jeannette Lee

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentBiostatistics, College of Medicine
DivisionBiostatistics Faculty/Staff
Address3212 ED III College of Public Health
220 UAMS Campus Dr.
Mail Slot # 781
Little Rock AR 72205
Phone501-526-6712
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionUniversity of Arkansas for Medical Sciences
    DepartmentCollege of Public Health


    Collapse Research Funds 
    Collapse research activities
    U24OD024957     (LEE, JEANNETTE)Sep 23, 2016 - Aug 31, 2025
    NIH/Nat. Inst. of Child Health & Human Development
    Data Coordinating and Operations Center (DCOC) for the IDeA States Pediatric Clinical Trials Network
    Role: Co-Principal Investigator

    HHSN272201300012     (LEE, JEANNETTE)Aug 5, 2016 - Feb 15, 2020
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham
    STI CTG Task Area 1, Task Order 10
    Role: Principal Investigator

    HHSN2722013000121     (LEE, JEANNETTE)Aug 5, 2016 - Feb 15, 2020
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham
    STI CTG Task Area 1, Task Order 10
    Role: Principal Investigator

    HHSN272201300012I     (LEE, JEANNETTE)Sep 15, 2015 - Sep 14, 2019
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham
    STICTG Infrastructure, TA 1, TO 11 - Continuation Year 2018-2019
    Role: Principal Investigator

    AIDS Malignancy - 5 UM1 CA121947-13     (LEE, JEANNETTE)Sep 1, 2015 - Aug 31, 2020
    NIH/Nat. Cancer Institute - Pass Through: University of California, Los Angeles
    AMC Statistical Center
    Role: Principal Investigator

    AMC 102 - 5 UM1 CA121947-13     (LEE, JEANNETTE)Sep 1, 2015 - Aug 31, 2020
    NIH/Nat. Cancer Institute - Pass Through: University of California, Los Angeles
    AMC Statistical Center
    Role: Principal Investigator

    ANCHOR - 5 UM1 CA121947-13     (LEE, JEANNETTE)Sep 1, 2015 - Aug 31, 2020
    NIH/Nat. Cancer Institute - Pass Through: University of California, Los Angeles
    AMC Statistical Center
    Role: Principal Investigator

    Covenant - 5 UM1 CA121947-13     (LEE, JEANNETTE)Sep 1, 2015 - Aug 31, 2020
    NIH/Nat. Cancer Institute - Pass Through: University of California, Los Angeles
    AMC Statistical Center
    Role: Principal Investigator

    Latin Study - 5 UM1 CA121947-13     (LEE, JEANNETTE)Sep 1, 2015 - Aug 31, 2020
    NIH/Nat. Cancer Institute - Pass Through: University of California, Los Angeles
    AMC Statistical Center
    Role: Principal Investigator

    UM1CA121947     (LEE, JEANNETTE)Sep 1, 2015 - Aug 31, 2020
    NIH/Nat. Cancer Institute - Pass Through: University of California, Los Angeles
    AMC Statistical Center
    Role: Principal Investigator

    U48DP005037     (LEE, JEANNETTE)Sep 30, 2014 - Sep 29, 2017
    Centers for Disease Control & Prevention - Pass Through: University of Alabama at Birmingham
    SIP 14-034: Prospective Study of Immune Response to Chlamydial Infection
    Role: Principal Investigator

    HHSN27200006     (LEE, JEANNETTE)Sep 15, 2014 - Sep 14, 2015
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham
    Sexually Transmitted Infections Clinical Trials Group II - Infrastructure
    Role: Principal Investigator

    U01AI108509     (LEE, JEANNETTE)Jul 17, 2014 - Jun 30, 2020
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham
    Randomized Clinical Trial of Male Partners of Women with Recurrent BV
    Role: Principal Investigator

    8153sc     (LEE, JEANNETTE)Jun 1, 2014 - Sep 30, 2014
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of California, San Francisco
    STI Clinical Trials Group - PVI Study Closeout
    Role: Principal Investigator

    HHSN266200400073C     (STEELMAN, SUSAN)May 1, 2014 - Apr 30, 2015
    NIH/National Library of Medicine - Pass Through: Houston Academy of Medicine-Texas Medical Center Library
    NN/LM SCAR Resource Library Outreach Subcontract 2014-2015 Pormoting NLM Resource
    Role: Principal Investigator

    R34AI100728     (LEE, JEANNETTE)Jun 15, 2012 - May 31, 2013
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham
    Randomized Trial of Male Partners of Women with Bacterial Vaginosis
    Role: Principal Investigator

    000410050-0001     (LEE, JEANNETTE)Dec 1, 2011 - Nov 30, 2016
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham
    Mechanisms and Correlates of Immune Protection against Genital Chlamydia in Human
    Role: Principal Investigator

    R01AI093692     (LEE, JEANNETTE)Dec 1, 2011 - Nov 30, 2016
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham
    Mechanisms and Correlates of Immune Protection against Genital Chlamydia in Human
    Role: Principal Investigator

    HHSN266200400074C     (LEE, JEANNETTE)Jul 1, 2011 - Dec 31, 2015
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of California, San Francisco
    Sexually Transmitted Infections Clinical Trials Group - SOV Study
    Role: Principal Investigator

    000209764-026     (LEE, JEANNETTE)Jul 1, 2011 - Jul 31, 2015
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham
    Sexually Transmitted Infections Clinical Trials Group - BRAVO Study Opt 3
    Role: Principal Investigator

    HHSN26620040074C     (LEE, JEANNETTE)Jul 1, 2011 - Jul 31, 2014
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of California, San Francisco
    Sexually Transmitted Infections Clinical Trials Group - PVI Study
    Role: Principal Investigator

    U01DK063788     (LEE, JEANNETTE)Sep 20, 2010 - Jun 30, 2012
    NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases - Pass Through: University of Alabama at Birmingham
    Complementary and Alternative Medicines for Urological Symptoms
    Role: Co-Principal Investigator

    U01CA121947     (LEE, JEANNETTE)Sep 1, 2010 - Aug 31, 2015
    NIH/Nat. Cancer Institute - Pass Through: EMMES Corp.
    AMC Statistical Center
    Role: Principal Investigator

    U01CA093344     (LEE, JEANNETTE)Sep 1, 2009 - Jul 31, 2012
    NIH/Nat. Cancer Institute - Pass Through: University of Alabama at Birmingham
    Cancer Care Outcomes Research and Surveillance Consortium II
    Role: Principal Investigator

    HHSN26620040073C(N01-AI-40073)     (LEE, JEANNETTE)Jun 1, 2008 - Sep 28, 2011
    NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham
    Statistical Center for the STI CTG
    Role: Principal Investigator

    U01CA114607     (HENRY-TILLMAN, RONDA)May 6, 2005 - Mar 31, 2013
    NIH/Nat. Cancer Institute
    Arkansas Cancer Community Network (AR-CCN)/Community Health Educators
    Role: Co-Investigator

    U01CA070019     (LEE, JEANNETTE Y.)Sep 30, 1995 - May 31, 2007
    NIH/NCI
    AMC OPERATIONS CENTER
    Role: Principal Investigator

    N01RG022114     (LEE, JEANNETTE Y.)Sep 30, 1992
    NIH/CSR
    ELECTRONIC GRANT APPLICATION DEVELOPMENT FIELD TRIAL
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Ramos JC, Sparano JA, Chadburn A, Reid EG, Ambinder RF, Siegel ER, Moore PC, Rubinstein PG, Durand CM, Cesarman E, Aboulafia D, Baiocchi R, Ratner L, Kaplan L, Capoferri AA, Lee JY, Mitsuyasu R, Noy A. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020 Sep 10; 136(11):1284-1297. PMID: 32430507.
      View in: PubMed
    2. Strother RM, Gopal S, Wirth M, Chadburn A, Noy A, Cesarman E, Lee JY, Remick SC, Busakhala N, Kaimila B, Mberi E, Ndlovu N, Omoding A, Krown SE. Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study. JCO Glob Oncol. 2020 07; 6:1034-1040. PMID: 32634068.
      View in: PubMed
    3. Hook EW, Newman L, Drusano G, Evans S, Handsfield HH, Jerse AE, Kong FYS, Lee JY, Taylor SN, Deal C. Development of New Antimicrobials for Urogenital Gonorrhea Therapy: Clinical Trial Design Considerations. Clin Infect Dis. 2020 03 17; 70(7):1495-1500. PMID: 31538646.
      View in: PubMed
    4. Sparano JA, Lee JY, Kaplan LD, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R. Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV- associated, B-cell non-Hodgkin's lymphoma. Haematologica. 2020 Feb 27. PMID: 32107337.
      View in: PubMed
    5. Goldstone SE, Lensing SY, Stier EA, Darragh T, Lee JY, van Zante A, Jay N, Berry-Lawhorn JM, Cranston RD, Mitsuyasu R, Aboulafia D, Palefsky JM, Wilkin T. A Randomized Clinical Trial of Infrared Coagulation Ablation Versus Active Monitoring of Intra-anal High-grade Dysplasia in Adults With Human Immunodeficiency Virus Infection: An AIDS Malignancy Consortium Trial. Clin Infect Dis. 2019 03 19; 68(7):1204-1212. PMID: 30060087.
      View in: PubMed
    6. Heo S, McSweeney J, Prewitt TE, Lee JY, Moser DK, Shaw-Devine A, Morell A, Kim J, Yeary KHK. A Tailored Dietary Sodium Intervention Using Technology and Psychosocial Support: A Pilot Study. J Cardiovasc Nurs. 2019 Mar/Apr; 34(2):137-140. PMID: 30358660.
      View in: PubMed
    7. Burkhalter JE, Aboulafia DM, Botello-Harbaum M, Lee JY. Participant characteristics and clinical trial decision-making factors in AIDS malignancy consortium treatment trials for HIV-infected persons with cancer (AMC #S006). HIV Clin Trials. 2018 12; 19(6):235-241. PMID: 30890062.
      View in: PubMed
    8. Seña AC, Lee JY, Schwebke J, Philip SS, Wiesenfeld HC, Rompalo AM, Cook RL, Hobbs MM. A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States. Clin Infect Dis. 2018 06 18; 67(1):73-79. PMID: 29342269.
      View in: PubMed
    9. Apewokin S, Lee JY, Goodwin JA, McKelvey KD, Stephens OW, Zhou D, Coleman EA. Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study. Support Care Cancer. 2018 Sep; 26(9):3127-3134. PMID: 29594489.
      View in: PubMed
    10. Ogendi BMO, Bakshi RK, Gupta K, Kapil R, Brown LT, Jordan SJ, Sabbaj S, Press CG, Lee JY, Geisler WM. T cell phenotypes in women with Chlamydia trachomatis infection and influence of treatment on phenotype distributions. Microbes Infect. 2018 03; 20(3):176-184. PMID: 29287991.
      View in: PubMed
    11. Ogendi BMO, Bakshi RK, Sabbaj S, Brown L, Lee JY, Kapil R, Geisler WM. Distinct peripheral vs mucosal T-cell phenotypes in chlamydia-infected women. Am J Reprod Immunol. 2017 Dec; 78(6). PMID: 28949051.
      View in: PubMed
    12. Royse KE, El Chaer F, Amirian ES, Hartman C, Krown SE, Uldrick TS, Lee JY, Shepard Z, Chiao EY. Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013. PLoS One. 2017; 12(8):e0182750. PMID: 28829790.
      View in: PubMed
    13. Bakshi RK, Gupta K, Jordan SJ, Brown LT, Press CG, Gorwitz RJ, Papp JR, Morrison SG, Lee JY, Morrison RP, Geisler WM. Immunoglobulin-Based Investigation of Spontaneous Resolution of Chlamydia trachomatis Infection. J Infect Dis. 2017 06 01; 215(11):1653-1656. PMID: 28444306.
      View in: PubMed
    14. Wagner-Johnston ND, Lensing S, Noy A, Ratner L, Henry D, Lee JY, Silver S, Faham M, Ambinder RF. High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064). Leuk Lymphoma. 2017 12; 58(12):2939-2942. PMID: 28508728.
      View in: PubMed
    15. Tummel E, Ochoa D, Korourian S, Betzold R, Adkins L, McCarthy M, Hung S, Kalkwarf K, Gallagher K, Lee JY, Klimberg VS. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy? Ann Surg. 2017 05; 265(5):987-992. PMID: 27163955.
      View in: PubMed
    16. Jordan SJ, Gupta K, Ogendi BMO, Bakshi RK, Kapil R, Press CG, Sabbaj S, Lee JY, Geisler WM. The Predominant CD4+ Th1 Cytokine Elicited to Chlamydia trachomatis Infection in Women Is Tumor Necrosis Factor Alpha and Not Interferon Gamma. Clin Vaccine Immunol. 2017 Apr; 24(4). PMID: 28100498.
      View in: PubMed
    17. Makhoul I, Todorova VK, Siegel ER, Erickson SW, Dhakal I, Raj VR, Lee JY, Orloff MS, Griffin RJ, Henry-Tillman RS, Klimberg S, Hutchins LF, Kadlubar SA. Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients. PLoS One. 2017; 12(1):e0168550. PMID: 28045923.
      View in: PubMed
    18. Sparano JA, Lee JY, Palefsky J, Henry DH, Wachsman W, Rajdev L, Aboulafia D, Ratner L, Fitzgerald TJ, Kachnic L, Mitsuyasu R. Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial. J Clin Oncol. 2017 Mar; 35(7):727-733. PMID: 27937092.
      View in: PubMed
    19. Lee JY, Dhakal I, Casper C, Noy A, Palefsky JM, Haigentz M, Krown SE, Ambinder RF, Mitsuyasu RT. Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy. J Cancer Epidemiol. 2016; 2016:2138259. PMID: 27882054.
      View in: PubMed
    20. Lee JY, Malak SF, Klimberg VS, Henry-Tillman R, Kadlubar S. Change in Mammography Use Following the Revised Guidelines from the U.S. Preventive Services Task Force. Breast J. 2017 Mar; 23(2):164-168. PMID: 27797121.
      View in: PubMed
    21. Bender Ignacio RA, Lee JY, Rudek MA, Dittmer DP, Ambinder RF, Krown SE. Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059. J Acquir Immune Defic Syndr. 2016 May 01; 72(1):52-7. PMID: 26689971.
      View in: PubMed
    22. Hernandez AL, Karthik R, Sivasubramanian M, Raghavendran A, Gnanamony M, Lensing S, Lee JY, Kannangai R, Abraham P, Mathai D, Palefsky JM. Prevalence of Anal HPV Infection Among HIV-Positive Men Who Have Sex With Men in India. . 2016 Apr 01; 71(4):437-43. PMID: 26379067.
      View in: PubMed
    23. Geisler WM, Uniyal A, Lee JY, Lensing SY, Johnson S, Perry RC, Kadrnka CM, Kerndt PR. Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection. N Engl J Med. 2015 Dec 24; 373(26):2512-21. PMID: 26699167.
      View in: PubMed
    24. Kaplan SA, Lee JY, Meehan AG, Kusek JW. Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial. J Urol. 2016 06; 195(6):1825-9. PMID: 26678956.
      View in: PubMed
    25. Schwebke JR, Lee JY, Lensing S, Philip SS, Wiesenfeld HC, Seña AC, Trainor N, Acevado N, Saylor L, Rompalo AM, Cook RL. Home Screening for Bacterial Vaginosis to Prevent Sexually Transmitted Diseases. Clin Infect Dis. 2016 Mar 01; 62(5):531-6. PMID: 26611782.
      View in: PubMed
    26. Epeldegui M, Lee JY, Martínez AC, Widney DP, Magpantay LI, Regidor D, Mitsuyasu R, Sparano JA, Ambinder RF, Martínez-Maza O. Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial). Clin Cancer Res. 2016 Jan 15; 22(2):328-36. PMID: 26384320.
      View in: PubMed
    27. Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 2015 Jul 09; 126(2):160-6. PMID: 25957391.
      View in: PubMed
    28. Erickson SW, Raj VR, Stephens OW, Dhakal I, Chavan SS, Sanathkumar N, Coleman EA, Lee JY, Goodwin JA, Apewokin S, Zhou D, Epstein J, Heuck CJ, Vangsted AJ. Genome-wide scan identifies variant in 2q12.3 associated with risk for multiple myeloma. Blood. 2014 Sep 18; 124(12):2001-3. PMID: 25237182.
      View in: PubMed
    29. Coleman EA, Lee JY, Erickson SW, Goodwin JA, Sanathkumar N, Raj VR, Zhou D, McKelvey KD, Apewokin S, Stephens O, Enderlin CA, Vangsted AJ, Reed PJ, Anaissie EJ. GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis. Support Care Cancer. 2015 Mar; 23(3):841-9. PMID: 25218607.
      View in: PubMed
    30. Lee JY, Klimberg S, Bondurant KL, Phillips MM, Kadlubar SA. Cross-sectional study to assess the association of population density with predicted breast cancer risk. Breast J. 2014 Nov-Dec; 20(6):615-21. PMID: 25200109.
      View in: PubMed
    31. Barta SK, Xue X, Wang D, Lee JY, Kaplan LD, Ribera JM, Oriol A, Spina M, Tirelli U, Boue F, Wilson WH, Wyen C, Dunleavy K, Noy A, Sparano JA. A new prognostic score for AIDS-related lymphomas in the rituximab-era. Haematologica. 2014 Nov; 99(11):1731-7. PMID: 25150257.
      View in: PubMed
    32. Koon HB, Krown SE, Lee JY, Honda K, Rapisuwon S, Wang Z, Aboulafia D, Reid EG, Rudek MA, Dezube BJ, Noy A. Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042. J Clin Oncol. 2014 Feb 10; 32(5):402-8. PMID: 24378417.
      View in: PubMed
    33. Lee JY, Moore PC, Steliga MA. Do HIV-infected non-small cell lung cancer patients receive guidance-concordant care? Med Care. 2013 Dec; 51(12):1063-8. PMID: 24220684.
      View in: PubMed
    34. Kaplan SA, Lee JY, O'Neill EA, Meehan AG, Kusek JW. Prevalence of low testosterone and its relationship to body mass index in older men with lower urinary tract symptoms associated with benign prostatic hyperplasia. Aging Male. 2013 Dec; 16(4):169-72. PMID: 24134648.
      View in: PubMed
    35. Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N, Kaplan LD, Ribera JM, Spina M, Tirelli U, Weiss R, Galicier L, Boue F, Wilson WH, Wyen C, Oriol A, Navarro JT, Dunleavy K, Little RF, Ratner L, Garcia O, Morgades M, Remick SC, Noy A, Sparano JA. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood. 2013 Nov 07; 122(19):3251-62. PMID: 24014242.
      View in: PubMed
    36. Van Wagoner, N, Morrow, R, Lee, J, Dixon, P, Hook, E. Serologic screening for herpes simplex virus type 2 in persons with human immunodeficiency virus. Am J Med Sci. 2013; 346(2):108-112.
    37. Lee JY, Lee JH, Yeo JS, Kim JJ. A SNP Harvester Analysis to Better Detect SNPs of CCDC158 Gene That Are Associated with Carcass Quality Traits in Hanwoo. Asian-Australas J Anim Sci. 2013 Jun; 26(6):766-71. PMID: 25049848.
      View in: PubMed
    38. Taylor SN, Lensing S, Schwebke J, Lillis R, Mena LA, Nelson AL, Rinaldi A, Saylor L, McNeil L, Lee JY. Prevalence and treatment outcome of cervicitis of unknown etiology. Sex Transm Dis. 2013 May; 40(5):379-85. PMID: 23588127.
      View in: PubMed
    39. Taylor, SN, Schwebke, J, Lensing, S, Lillis, R, Mena, LA, Nelson, AL, Rinaldi, A, Saylor, L, McNeil, L, Lee, JY. Prevalence and treatment outcomes of cervicitis of unknown etiology. Sexually Transmitted Diseases. 2013; 40(5):379-385.
    40. Avins, AL, Lee, JY, Meyers, CM, Barry, MJ. Safety and toxicity of saw palmetto in the Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Trial. J Urol. 2013; 189(4):1415-1420.
    41. Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry MJ, Jay N, Aboulafia DM, Einstein MH, Saah A, Mitsuyasu RT, Palefsky JM. High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine. HIV Clin Trials. 2013 Mar-Apr; 14(2):75-9. PMID: 23611828.
      View in: PubMed
    42. Fouad MN, Lee JY, Catalano PJ, Vogt TM, Zafar SY, West DW, Simon C, Klabunde CN, Kahn KL, Weeks JC, Kiefe CI. Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract. 2013 Mar; 9(2):e40-7. PMID: 23814523.
      View in: PubMed
    43. Fouad, MN, Lee, JY, Catalano, PJ, Vogt, TM, Zafar, SY, West, DW, Simon, C, Klabunde, CN, Kahn, KL, Weeks, JC, Kiefe, CL. Enrollment of lung and colorectal cancer patients in clinical trials. Journal of Oncology Practice. 2013; 9(2):e40-47.
    44. Stier EA, Goldstone SE, Einstein MH, Jay N, Berry JM, Wilkin T, Lee JY, Darragh TM, Da Costa M, Panther L, Aboulafia D, Palefsky JM. Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women. AIDS. 2013 Feb 20; 27(4):545-51. PMID: 23032420.
      View in: PubMed
    45. Lee JY, Moore P, Kusek J, Barry M. Treatment assignment guesses by study participants in a double-blind dose escalation clinical trial of saw palmetto. J Altern Complement Med. 2014 Jan; 20(1):48-52. PMID: 23383975.
      View in: PubMed
    46. Catalano, PJ, Ayanian, JZ, Weeks, JC, Kahn, KL, Landrum, MB, Zaslavsky, A, Lee, J, Pendergast, J, Harrington, DP, Lee. Representativeness of participants in the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium relative to the Surveillance, Epidemiology and End Results (SEER) Program. Medical Care. 2013; 51(2):e9-15.
    47. Fwu CW, Eggers PW, Kaplan SA, Kirkali Z, Lee JY, Kusek JW. Long-term effects of doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia. J Urol. 2013 Jul; 190(1):187-93. PMID: 23357210.
      View in: PubMed
    48. Levine, AM, Noy, A, Lee, JY, Tam, W, Ramos, JC, Henry, DH, Parekh, S, Reid, EG, Mitsuyasu, R, Cooley, T, Dezube, BJ, Ratenr, L, Cesarman, E, Tulpule, A, Lee. Liposomal doxorubicin, rituximab, cyclophosphamide, vincristine and prednisone (DR-COP) in AIDS-related lyphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol. 2013; 31(1):58-64.
    49. Helfand, BT, Lee, JY, Sharp, V, Foster, H, Naslund, M, Williams, OD, McVary, KT, For the CAMUS Study Group, Lee. Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial. J Urol. 2012; 188(6):2288-93.
    50. Lee JH, Park DH, Back DB, Lee JY, Lee CI, Park KJ, Kang SH, Cho TH, Chung YG. Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: a pilot study. Med Sci Monit. 2012 Dec; 18(12):PR19-25. PMID: 23197244.
      View in: PubMed
    51. Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A. Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol. 2013 Jan 01; 31(1):58-64. PMID: 23169503.
      View in: PubMed
    52. Avins AL, Lee JY, Meyers CM, Barry MJ. Safety and toxicity of saw palmetto in the CAMUS trial. J Urol. 2013 Apr; 189(4):1415-20. PMID: 23063633.
      View in: PubMed
    53. Barta, SK, Lee, JY, Kaplan, LD, Noy, A, Sparano, JA. Pooled analysis of AIDS-Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin's lymphoma. Cancer. 2012; 118(16):3977-3983.
    54. Sena, AC, Lensing, S, Rompalo, A, Taylor, S, Martin, DA, Lopez, LM, Lee, JY, Schwebke, JR. Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in symptomatic men with non-gonococcal urethritis: predictors of infection and persistence after therapy. J Inf Dis. 2012; 206(3):357-365.
    55. Garg, M, Lee, JY, Kachnic, LA, Catalano, PJ, Henry, DH, Cooley, TP, Ratner, L, Wachsman, W, Aboulafia, DM, Benson, AB, Palefsky, J, Whittington, R, Mitsuyasu, RT, Sparano, JA. Phase II trials of cetuximab (CX) plus cisplatin (CDDP), 5-fluorouracil (5-FU) and radiation (RT) in immunocompetent (ECOG 3205) and HIV-positive (AMC045) patients with squamous cell carcinoma of the anal canal (SCAC); safety and preliminary results. 2012.
    56. Barta, SK, Xue, X, Ramari, R, Lee, JY, Mounier, N, Kaplan, LD, Ribera, J-M, Spina, M, Weiss, R, Galicier, L, Boue, F, Wilson, WH, Wyen, C, Navarro, J-T, Dunleavy, K, Little, RF, Ratner, L, Morgades, M, Garcia, O, Sparano, JA. A pooled analysis of 1,144 patients with HIV-associated lymphoma: assessment of lymphoma-, HIV-, and treatment-specific factors on clinical outcome. 2012.
    57. Seña AC, Lensing S, Rompalo A, Taylor SN, Martin DH, Lopez LM, Lee JY, Schwebke JR. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis. 2012 Aug 01; 206(3):357-65. PMID: 22615318.
      View in: PubMed
    58. Lee, J, Barry, M, Kusek J, For the CAMUS investigators. Participant perception of treatment assignment is related to symptom severity in a clinical trial of phytotherapy. 2012.
    59. Crawford, ED, Sullivan, KF, Arangua, P, Lee, J, Lensing, S, O'Donnell, CL. Comparison of the American Urological Association Symptom Index with a short version, UWIN, in a clinical phytotherapy trial. 2012.
    60. Kaplan, S, Lee, J, Kusek, J. Long-term treatment with finasteride resulted in a greater improvement relative to placebo in urinary symptoms in men with enlarged prostates examined by deciles (>30mL. >40mL, >50mL) compared to those with smaller prostates (<30mL); data from the Medical Therapy of Prostatic Symptoms (MTOPS) Trial. 2012.
    61. Helfand, BT, Sharp, V, Williams, OD, Foster, H, Naslund, M, Lee, J, McVary, KT. Improvements in lower urinary tract symptom severity are associated with improvements in sleep disturbance over time. 2012.
    62. Krown SE, Roy D, Lee JY, Dezube BJ, Reid EG, Venkataramanan R, Han K, Cesarman E, Dittmer DP. Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. . 2012 Apr 15; 59(5):447-54. PMID: 22067664.
      View in: PubMed
    63. Lee JY, Moore PC, Lensing SY. Impact of HIV Infection on Medicare Beneficiaries with Lung Cancer. J Cancer Epidemiol. 2012; 2012:706469. PMID: 22548059.
      View in: PubMed
    64. Lee JY, Lensing SY, Schwebke JR. Retention of clinical trial participants in a study of nongonococcal urethritis (NGU), a sexually transmitted infection in men. Contemp Clin Trials. 2012 Jul; 33(4):606-10. PMID: 22261236.
      View in: PubMed
    65. Barta SK, Lee JY, Kaplan LD, Noy A, Sparano JA. Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma. Cancer. 2012 Aug 15; 118(16):3977-83. PMID: 22180164.
      View in: PubMed
    66. Epeldegui, M, Widney, DP, Martinez, AC, Regidor, D, Magpantay, L, Mitsuyasu, M, Sparano, JA, Lee, JY, Ambinder, RF, Martinez-Maza, O. Serum levels of several molecules that are associated with B cell activation and inflammation are elevated in AIDS-associated non-Hodgkin's lymphoma (AIDS-NHL) and predict response to treatment. 2011.
    67. Lee, JY, Moore, PC. Prevalence of HIV in Medical Beneficiaries with Lung Cancer. 2011.
    68. Noy, A, Kaplan, L, Lee, J, Cesaman, E, Tam, W. Modified dose intensive R-CODOX-M/IVAC for HIV-associated Burkitt (BL) (AMC048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 Expression. 2011.
    69. Lee, J, Enoch, K, Fincher, R, Kenney, P, Jackson, S, Buie, H, Strickland, S, Preston, M, Henry-Tillman, R. Community partnerships are vital to the success of mobile mammography. 2011.
    70. McCarthy, DD, Kujawa, J, Wilson, C, Papandile, A, Porici, U, Porfilio, EA, Ward, L, Lawson, MA, Macpherson, AJ, McCoy, KD, Pei, Y, Novak, L, Lee, JY, Julian, BA, Novak, J, Ranger, A, Gommerman, JL, Browning, JL. Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest. 2011; 121(10):3991-4002.
    71. Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, Roehrborn CG, Crawford ED, Foster HE, Kaplan SA, McCullough A, Andriole GL, Naslund MJ, Williams OD, Kusek JW, Meyers CM, Betz JM, Cantor A, McVary KT. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA. 2011 Sep 28; 306(12):1344-51. PMID: 21954478.
      View in: PubMed
    72. Barry, MJ, Meleth, S, Lee, JY, Kreder, KJ, Avins, AL, Nickel, JC, Roehrborn, CG, Crawford, ED, Foster, HE Jr, Kaplan, SA, McCollough, A, Andriole, G, Naslund, MJ, Williams, OD, Kusek, JW, Meyers, CM, Betz, JM, Cantor, A, McVary, KT. Effect of increasing doses of saw palmetto on lower urinary tract symptoms. JAMA. 2011; 306(12):1344-1351.
    73. Lee, JY, Henry-Tillman, RS, Klimberg, VS, Fincher, R, Enoch, K, Preston, M, Jackson, S, Kenney, P. Use of patient navigation to improve diagnostic and treatment delays among patients with abnormal mammography results from a mobile unit. 2011.
    74. Yu SH, Lee JY, Jeon CJ. Immunocytochemical localization of calcium-binding proteins, calbindin D28K-, calretinin-, and parvalbumin-containing neurons in the dog visual cortex. Zoolog Sci. 2011 Sep; 28(9):694-702. PMID: 21882959.
      View in: PubMed
    75. Martin MY, Pisu M, Oster RA, Urmie JG, Schrag D, Huskamp H, Lee J, Kiefe C, Fouad M. Racial Variation in Willingness to Trade Financial Resources for Life Prolonging Cancer Treatment. Cancer. 2011; 117(15):3476-84.
    76. Noy, A, Kaplan, L, Lee, J. Efficacy and tolerability of a modified dose intensive R-CODOX-M/IVAC for HIV-associated Burkitt and Atypical Burkitt Lymphoma (BL): Prospective multicenter phase II trial of the AIDS Malignancy Consortium (AMC). 2011.
    77. Lee JY, Foster HE, McVary KT, Meleth S, Stavris K, Downey J, Kusek JW. Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia. J Altern Complement Med. 2011 May; 17(5):469-72. PMID: 21554128.
      View in: PubMed
    78. Wagner-Johnston, ND, Gellert, L, Gocke, CD, Lemas, MV, Lee, J, Martinez-Mara, O, Ambinder, RF. Clonal immunoglobulin DNA in the plasma of patients with AIDS-lymphoma. Blood. 2011; 117(18):4860-62.
    79. Lee, J, Lensing, S, Schwebke, J. Retention of clinical trial participants in a study of non-gonococcal urethritis, a sexually transmitted infection. 2011.
    80. Lee JY, Moore PC, Lensing SY. The Accuracy of Clinical Trial Inferences: The Saw Palmetto Experience. 2011.
    81. Lee, J, Kusek, J. Association of baseline self-reported diabetes mellitus with 12 month change in lower urinary tract symptoms and prostate size: post-hoc analysis of the MTOPS study. 2011.
    82. Kaplan SA, Lee JY, Meehan AG, Kusek JW. Long-term treatment with finasteride resulted in a significant improvement relative to placebo in clinical progression of BPH in men with enlarged prostates (>= 30ml), but not in those with smaller prostates (<30 ml). J Urol. 2011; 185:1369-73.
    83. Kaplan SA, Lee JY, Meehan AG, Kusek JW. Long-term treatment with finasteride improves clinical progression of benign prostatic hyperplasia in men with an enlarged versus a smaller prostate: data from the MTOPS trial. J Urol. 2011 Apr; 185(4):1369-73. PMID: 21334655.
      View in: PubMed
    84. Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE. Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. . 2011 Jan 01; 56(1):64-8. PMID: 21068672.
      View in: PubMed
    85. Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE. Phase II Trial of Topical Halofuginone in Patients with HIV-related Kaposi’s Sarcoma, a Multicenter Trial for the AIDS Malignancy Consortium. J Acquir Def Syndr. 2011; 56(1):64-84.
    86. Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, Jay N, Aboulafia D, Cohn DL, Einstein MH, Saah A, Mitsuyasu RT, Palefsky JM. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J Infect Dis. 2010 Oct 15; 202(8):1246-53. PMID: 20812850.
      View in: PubMed
    87. Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, Ambinder RF, Lee JY, Krown SE, Sparano JA. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. 2010 Aug 15; 116(16):3969-77. PMID: 20564162.
      View in: PubMed
    88. Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, Ambinder RF, Lee JY, Krown SE, Sparano JA. Randomized Trial of Paclitaxel versus Pegylated Liposomal Doxorubicin for Advanced Human Immunodeficiency Virus-associated Kaposi’s Sarcoma: Evidence for Symptom Palliation from Chemotherapy. Cancer. 2010; 116(16):3969-3977.
    89. Stier, EA, Goldstone, SE, Einstein, MH, Jay, N, Berry, JM, Wilkin, T, Lee, J, Panther, LA, Aboulafia, D, Palefsky, JM. Phase IIA trial of 1% topical cidofoir for treatment of high-grade perianal squamous intrapepithelial neoplasia in HIV-infected men and women (AMC046). 2010.
    90. Stier EA, Goldstone SE, Einstein MH, Jay N, Berry JM, Wilkin T, Lee J, Panther LA, Aboulafia D, Palefsky JM. Phase IIA trial of 1% topical cidofoir for treatment of high-grade perianal squamous intrapepithelial neoplasia in HIV-infected men and women. 2010.
    91. Lee JY, Enoch K, Gibson R, Stewart C, Fincher R, Bland K, Thompson M, Klimberg VS, Henry-Tillman RS. Impact of Mobile Mammography Among the Medically Underserved. J Clin Oncol. 2010.
    92. Deeken, JF, Mitsuyasu, RT, Little, RF, Ivy, SP, Ambinder, RF, Rudek, MA, Lee, JY, Moore, PC, Mosby, K, Dezube, BJ. Treating HIV+ patients for non-AIDS-defining cancers (NADCs) in the era of targeted chemotherapy: an AIDS malignancy consortium study of sunitinib in patients on ART. 2010.
    93. Lee, JY, Foster, HE Jr, McVary, KT, Downey, J, Stavris, K, Meleth, S, Kusek, JW. Recruitment to a clinical trial of botanical therapy for benign prostatic Hyperplasia. 2010.
    94. Krown, SE, Fingleton, B, Lee, JY, Egorin, MJ, Koon, HB. Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi's Sarcoma (KS): clinical and biological effects using a novel intra-patient control design. 2010.
    95. Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Von Roenn J, Dezube BJ, Remick SC, Shah MH, Leichman L, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-assicated B-cell non-Hodgkins Lymphoma. Blood. 2010; 115(15):3008-16.
    96. Barta, SK, Lee, JY, Sparano, JA, Kaplan, LD, Noy, A, For the AIDS Malignancy Consortium. Pooled analysis of AIDS Malignancy Consortium trials evaluating Rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin's lymphoma. 2010.
    97. Lee, JY, Moore, PC, Lensing, SY, Lee. Sample size re-estimation using an internal pilot study with Poisson rates and adjustment to the nomimal p-value. 2010.
    98. Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Von Roenn J, Dezube BJ, Remick SC, Shah MH, Leichman L, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 2010 Apr 15; 115(15):3008-16. PMID: 20023215.
      View in: PubMed
    99. Lechowicz M, Dittmer DP, Lee JY, Krown SE, Wachsman W, Aboulafia D, Dezube BJ, Ratner L, Said J, Ambinder RF. Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clin Infect Dis. 2009 Dec 15; 49(12):1946-9. PMID: 19911999.
      View in: PubMed
    100. Lee J, Andriole G, Avins A, Crawford ED, Foster H, Kaplan S, Kreder K, Kusek J, McCullough A, McVary K, Meleth S, Naslund M, Nickel JC, Nyberg L, Roehrborn C, Dale Williams O, Barry M. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Clin Trials. 2009 Dec; 6(6):628-36. PMID: 20007408.
      View in: PubMed
    101. Noy, A, Kaplan, L, Lee, J. Modified Dose Intensive R- CODOX-M/IVAC for HIV-Associated Burkitt and Atypical Burkitt Lymphoma (BL): Preliminary Results of a Prospective Multicenter Phase II Trial of the AIDS Malignancy Consortium. 2009.
    102. Lechowicz MJ, Dittmer DP, Lee JY, Krown SE, Wachsman W, Aboulafia D, Dezube BJ, Ratner L, Said J, Ambinder RF. Molecular and clinical assessment in the treatment of AIDS Kaposi's Sarcoma with valproic acid. Clin Inf Dis. 2009; 49:1946-49.
    103. Lee ES, Lee JY, Jeon CJ. Types and density of calretinin-containing retinal ganglion cells in mouse. Neurosci Res. 2010 Feb; 66(2):141-50. PMID: 19895859.
      View in: PubMed
    104. Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Clinical Trials 010 and 034. J Clin Oncol. 2009; 27(30):5039-48.
    105. Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol. 2009 Oct 20; 27(30):5039-48. PMID: 19752343.
      View in: PubMed
    106. Lee, JY, Moore, PC, Lensing, SY. Sample size re-estimation for Poisson distributed variables with partial follow-up. 2009.
    107. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson T, Tomana M, Tomino Y, Mestecky J, Novak J. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. 2009; 119(6):1668-1677.
    108. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 2009 Jun; 119(6):1668-77. PMID: 19478457.
      View in: PubMed
    109. Kvale EA, Murthy R, Taylor R, Lee JY, Nabors LB. Distress and quality of life in primary high-grade brain tumor patients. Support Care Cancer. 2009 Jul; 17(7):793-9. PMID: 19421789.
      View in: PubMed
    110. Lee, JY, For the CAMUS Investigators. Re-design of the NIH Complementary and Alternative Medicine for Urological Symptoms Trial Based on Results from Another NIH-Supported Trial. 2009.
    111. Lin L, Lee JY, Kaplan LD, Dezube BJ, Noy A, Krown SE, Levine AM, Yu Y, Hayward GS, Ambinder RF. Chemotherapy in AIDS-Associated lymphoma leads to disappearance of KSHV DNA from blood. J Clin Oncol. 2009; 27(15):2496-2502.
    112. Lin L, Lee JY, Kaplan LD, Dezube BJ, Noy A, Krown SE, Levine AM, Yu Y, Hayward GS, Ambinder RF. Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. J Clin Oncol. 2009 May 20; 27(15):2496-502. PMID: 19349542.
      View in: PubMed
    113. Choi JS, Lee JY, Jeon CJ. Glutamate receptors GluR1 and GluR4 in the hamster superior colliculus: distribution and co-localization with calcium-binding proteins and GABA. Acta Histochem Cytochem. 2009 Apr 28; 42(2):29-38. PMID: 19492025.
      View in: PubMed
    114. Ratner L, Harrington W, Feng X, Grant C, Jacobson S, Noy A, Sparano J, Lee J, Ambinder R, Campbell N, Larimore M. Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PLOS One. 2009; 4(2):e4420.
    115. Schwebke JR, River C, Lee J. Prevalence of Gardnerella vaginalis in male sexual partners of women with and without bacterial vaginosis. Sex Transm Dis. 2009; 36(2):92-4.
    116. Kvale EA, Murthy RK, Lee JY, Taylor R, Nabors LB. Distress and quality of life in glioblastoma patients. J Support Oncol. 2009; 407.
    117. Wen Y-j, Zhao, W-z, Grazziutti M, Ling W, Lee J, Rhee F, Barlogie B, Anaissie E. Baseline platelet count predicts outcome of invasive aspergillosis among neutropenic patients with multiple myeloma. American Society of Hematology. 2009; 112:4353.
    118. Kaplan SA, Roehrborn CG, McConnell JD, Meehan AG, Surynawashi S, Lee JY, Rotonda J, Kusek JW, Nyberg LM. Long-term treatment with finasteride results in a clinical significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the Medical Therapy of Prostatic Symptoms (MTOPS) Trial. J Urol. 2008; 180(3):1030-1032.
    119. Kaplan SA, Roehrborn CG, McConnell JD, Meehan AG, Surynawanshi S, Lee JY, Rotonda J, Kusek JW, Nyberg LM. Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial. J Urol. 2008 Sep; 180(3):1030-2; discussion 1032-3. PMID: 18639298.
      View in: PubMed
    120. Fouad, M, Lee, J, Kiefe, C, Catalano, P, Vogt, T, Lee. Why do cancer patients rarely participate in clinical trials?. American Society of Clinical Oncology. 2008.
    121. Levine, AM, Lee, J, Kaplan, L, Liebes, L, Sparano, JA, Lee. Efficacy and toxicity of concurrent rituximab plus infusional EPOCH is effective and not associated with increased toxicity in HIV-associated lymphoma: AIDS Malignancy Consortium Trial 034. American Society of Clinical Oncology. 2008.
    122. Brinker BT, Krown SE, Lee JY, Cesarman E, Chadburn A, Kaplan LD, Henry DH, Von Roenn JH. Phase I/II Trial of BMS-275271 in patients with HIV-related Kaposi's Sarcoma. Cancer. 2008; 112:1083-8.
    123. Brinker BT, Krown SE, Lee JY, Cesarman E, Chadburn A, Kaplan LD, Henry DH, Von Roenn JH. Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium. Cancer. 2008 Mar 01; 112(5):1083-8. PMID: 18224669.
      View in: PubMed
    124. Mullins C, Lucia MS, Hayward SW, Lee JY, Levitt JM, Lin VK, Liu BC, Chinnaiyan AM, Rubin MA, Slawin K, Star RA, Getzenberg RH. A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA Consortium. J Urol. 2008 Apr; 179(4):1243-56. PMID: 18280515.
      View in: PubMed
    125. Krown SE, Lee JY, Dittmer DP. More on HIV-associated Kaposi's sarcoma. N Engl J Med. 2008 Jan 31; 358(5):535-6; author reply 536. PMID: 18234764.
      View in: PubMed
    126. Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, Aboulafia DM, Scadden DT. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant. 2008 Jan; 14(1):59-66. PMID: 18158962.
      View in: PubMed
    127. Martin M, Pisu M, Lee J, Fouad MA, Kiefe C. Life Extending Treatment at All Cost. 2008.
    128. Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Straus DJ, Scadden DT. Dose-reduced busulfan, cyclophosphamide and autologus stem cell transplantation for HIV-associated lymphoma. Biol Blood Marrow Transplant. 2008; 14(1):59-66.
    129. Krown SE, Lee JY, Dittmer DP. More on HIV-associated Kaposi's Sarcoma. N Engl J Med. 2008; 358(5):535-6.
    130. Stier EA, Goldstone SE, Berry M, Panther L, Jay N, Krown SE, Lee J, Palefsky JM. Infrared coagulator for treatment of anal high grade squamous intraepithelial neoplasia in HIV-infected individuals: a pilot study. J Acquir Immune Defic syndr. 2008; 47(1):56-61.
    131. Lechowicz, MJ, Lee, J, Dittmer, D, Krown, S, Said, J, Ambinder, R. A pilot trial of valproic acid in patients with Kaposi's Sarcoma: a multi-center trial of the AIDS Malignancy Consortium. 2007.
    132. Suzuki, H, Moldoveanu, Z, Hall, S, Brown, R, Julian, BA, Wyatt, RJ, Lee, JY, Tomana, M, Tomino, Y, Mestecky, J, Novak, J. Immunoglobulin-producing cell lines from patients with Henoch-Schoenlein Purpura (HSP) Nephritis secrete aberrantly-glycosylated IgA1 and anti-glycan IgG antibodies. 2007.
    133. Lee JY, Choi JS, Ye EA, Kim HH, Jeon CJ. Organization of calbindin D28K-immunoreactive neurons in the dog superior colliculus. Zoolog Sci. 2007 Nov; 24(11):1103-14. PMID: 18348611.
      View in: PubMed
    134. Lau K, Wyatt R, Moldoveanu Z, Tomana M, Julian BA, Hogg R, Lee J, Huang W-Q, Mestecky J, Novak J. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schoenlein purpura. Pediatr Nephrol. 2007; 22(12):2067-2072.
    135. Jeon YK, Kim TJ, Lee JY, Choi JS, Jeon CJ. AII amacrine cells in the inner nuclear layer of bat retina: identification by parvalbumin immunoreactivity. Neuroreport. 2007 Jul 16; 18(11):1095-9. PMID: 17589306.
      View in: PubMed
    136. Moldoveanu Z, Wyatt RJ, Lee J, Tomana M, Julian BA, Mestecky J, Huang W-Q, Anreddy SR, Hall S, Hastings C, Lau KK, Cook WJ, Novak J. Elevated serum levels of galactose-deficient IgA in patients with IgA nephropathy. Kidney Int. 2007; 71:1148-54.
    137. Chadburn, A, Chen, X, Hujek, E, Tam, W, Kaplan, LD, Sparano, JA, Lee, J, Scadden, DT, Chiu, A, Knowles, DM, Cesarman, E, And the AIDS Malignancies Consortium. Neither Germinal center (GC) vs. non-germinal center (non-GC) phenotype nor FOXP1 expression correlate with outcome in AIDS-associated diffuse large B-cell lymphoma (DLBCL): study of patients from AIDS Malignancies Consortium Trials 010 and 034. 2006.
    138. Sparano, JA, Lee, JY, Kaplan, LD. Randomized phase II trial of infusional EPOCH chemotherapy given concurrently or sequentially with rituximab in HIV-associated lymphoma (AMC034). 2006.
    139. Jeong SA, Kwon OJ, Lee JY, Kim TJ, Jeon CJ. Synaptic pattern of AMPA receptor subtypes upon direction-selective retinal ganglion cells. Neurosci Res. 2006 Dec; 56(4):427-34. PMID: 17007948.
      View in: PubMed
    140. Palefsky JM, Berry JM, Jay N, Krogstad M, Da Costa M, Darragh TM, Lee JY. A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals. AIDS. 2006 May 12; 20(8):1151-5. PMID: 16691066.
      View in: PubMed
    141. Palefsky JM, Berry JM, Jay N, Krogstad M, DaCosta M, Darragh T, Lee JY. A trial of SGN-00101(HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals. AIDS. 2006; 20(8):1151-5.
    142. Dezube BJ, Krown SE, Lee JY, Bauer KS, Aboulafia DM. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol. 2006 Mar 20; 24(9):1389-94. PMID: 16549833.
      View in: PubMed
    143. Dezube BJ, Krown SE, Lee JY, Bauer KS, Aboulafia DM. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's Sarcoma: a randomized phase II AIDS Malignancy Consortium Study. J Clin Oncol. 2006; 24:1389-94.
    144. Krown SE, Lee JY, Lin L, Fischl MA, Ambinder R, Von Roenn JH. Interferon alfa-2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi's sarcoma: an AIDS Malignancy Consortium Phase I Trial. J Acquir Immune Defic syndr. 2006; 41:149-53.
    145. Krown SE, Lee JY, Lin L, Fischl MA, Ambinder R, Von Roenn JH. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. . 2006 Feb 01; 41(2):149-53. PMID: 16394845.
      View in: PubMed
    146. Robbin ML, Oser RF, Lee JY, Heudebert GR, Mennemeyer ST, Allon M. Randomized clinical trial comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney Int. 2006; 69:730-5.
    147. Hoff RJ, Lee J, Nardelli N, Julian BA, Cattran D, Waldo B, Wyatt R, Jennette C, Sibley R, Hyland K, Fitzgibbons L, Hirschman G, Donadio J, Holub BJ. Placebo-controlled clinical trial evaluating omega-3 fatty acids and alternative day prednisone in patients with IgA nephropathy. Clin J Am Soc Nephrol. 2006; 1:467-74.
    148. Moldoveanu, Z, Wyatt, RJ, Novak, J, Lee, J, Julian, BA, Tomana, M, Mestecky, J. Elevated serum creatinine concentration of Helix aspersa lectin-binding IgA1 (HAA-IgA1) in pediatric patients with IgA Nephropathy (IgAN). 2005.
    149. Novak, J, Wittke, S, Haubitz, M, Walden, M, Moldoveanu, Z, Nichols, CR, Kirksey, C, Lee, J, Hall, S, Brown, R, Renfrow, M, Matousovic, K, Julian, BA, Wyatt, R, Tomana, M, Mestecky, J, Mischak, H. Urinary protein analyses reveal patterns and biomarkers specific for IgA Nephropathy. 2005.
    150. Robbin, ML, Oser, RL, Lee, JY, Heudebert, GR, Mennemeyer, ST. Randomized clinical trial comparison of ultrasound surveillance and clinical monitoring on Arteriovenous Graft Outcomes. 2005.
    151. Kaplan LD, Lee JY, Ambinder R, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Rituximab does not improve clinical outcome in a randomized phase III trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin's lymphoma. Blood. 2005; 106(5):1538-43.
    152. Rostand SG, Cross SK, Kirk KA, Lee JY, Kuhlmann A, Amann K. Racial differences in renal arteriolar structure in children with minimal change nephropathy. Kidney Int. 2005 Sep; 68(3):1154-60. PMID: 16105046.
      View in: PubMed
    153. Rostand SG, Cross SK, Kirk KA, Lee JY, Kuhlmann A, Amann K. Racial differences in renal arteriolar luminal diameter are independent of blood pressure. Kidney Int. 2005; 68(3):1154-60.
    154. Woodberry T, Henry LM, O'Connor PG, Davis JK, Suscovich TJ, Martin JN, Osmond D, Kedes DH, Lee J, Walker BD, Scadden DT, Brander C. Impact of co-infection and viral loads on the detection of cytotoxic T-lymphocyte responses to Kaposi's sarcoma associated herpesvirus (KSHV/HHV8) LANA (ORF-73) and ORF-65 proteins. J Infect Dis. 2005; 192(4):622-9.
    155. Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 2005 Sep 01; 106(5):1538-43. PMID: 15914552.
      View in: PubMed
    156. Noy, A, David, DR, Lee, J, Dezube, BJ, Aboulafia, D, Tulpule, A, Walmsley, S, Gill, P. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's Sarcoma in a phase III trial, but highlights sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 study team. J Clin Oncol. 2005; 23(5):1-9.
    157. Morgan SL, Oster RA, Lee JY, Alarcon GS, Baggott JE. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. Arthritis Rheum. 2004; 50(10):3104 - 3111.
    158. Morgan SL, Oster RA, Lee JY, Alarcón GS, Baggott JE. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. Arthritis Rheum. 2004 Oct; 50(10):3104-11. PMID: 15476202.
      View in: PubMed
    159. Lee, J, For the AIDS Malignancy Consortium. Pain and appearance are related to response to treatment in AIDS-related Kaposi's sarcoma. 2004.
    160. Van Burik, JA, Ratanatharathorn, V, Stepan, DE, Miller, CB, Lipton, JH, Vesole, DH, Bunin, N, Wall, DA, Hiemenz, JW, Satoi, Y, Lee, J, Walsh, TJ, NIAID Mycoses Study Group. Micafungin versus fluconzole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantion. Clin Infect Dis. 2004; 39(10):1407-16.
    161. Kaplan, LD, Lee, J, Scadden, DT. No benefit from Rituximab in a randomized phase III trial of CHOP with or without Rituximab for patients with HIV-associated non-hodgkin's lymphoma: Updated data from the AIDS Malignancies Consortium Study 010. 2003.
    162. Miller, LG, Man, D, Lee, C, Lee, JY, Dismukes, WE, Kauffman, C, And the NIAID Mycoses Study Group. Predictors of candiduria resolution in hospitalized patients: a prospective milti-center investigation. 2003.
    163. Kaplan, LD, Lee, J, Caligiuri, M, Von Roenn, J, Levine, A, Harrington, W, Scadden, D, For the AIDS Associated Malignancies Consortium. A randomized phase III trial of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) with or without Rituximab for patients with HIV-associated non-Hodgkin's lymphoma: AIDS Malignancies Consortium Study 010. 2003.
    164. Bennett, JE, Powers, J, De Pauw, B, Dismukes, W, Galgiani, J, Glauser, M, Herbrecht, R, Lee, J, Pappas, P, Rex, J, Verweij, P, Viscoli, C, Walsh, T. Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis. Clin Infect Dis. 2003; 36(Suppl 3):S113-6.
    165. Pappas, PG, Rex, JH, Lee, J, Hamill, RJ, Larsen, RA, Powderly, W, Kauffman, CA, Hyslop, N, Mangino, JE, Chapman, S, Horowitz, HW, Edwards, JE, Dismukes, WE, And the NIAID Mycoses Study Group. A prospective observational study of candidemia: epidemiology, therapy and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003; 37(5):634-43.
    166. Ostrosky-Zeichner, L, Rex, JH, Pappas, PG, Hamill, RJ, Larsen, RA, Horowitz, HW, Powderly, WG, Hyslop, N, Kauffman, CA, Cleary, J, Mangino, JE, Lee, J, For the NIAID Mucoses Study Group Candidiasis Subproject. Antifungal Susceptibility Survey of 2,000 Bloodstream Candida isolates in the United States. Antimicrob agents Chemother. 2003; 47(10):3149-54.
    167. Morgan SL, Abercrombie W, Lee JY. Need for precision studies at individual institutions and assessment of size of regions of interest on serial DXA scans. J Clin Densitom. 2003; 6(2):97-101. PMID: 12794231.
      View in: PubMed
    168. Bennett, JE, Kauffman, C, Walsh, T, De Pauw, B, Dismukes, W, Galgiani, J, Glauser, M, Herbrecht, R, Lee, J, Pappas, P, Powers, J, Rex, J, Verweij, P, Viscoli, C. Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups. Clin Infect Dis. 2003; 36(Suppl 3):S123-7.
    169. Bennett, JE, Powers, J, Walsh, T, Viscoli, C, De Pauw, B, Dismukes, W, Galgiani, J, Glauser, M, Herbrecht, R, Kauffman, C, Lee, J, Pappas, P, Rex, J, Verweij, P. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. Clin Infect Dis. 2003; 36(Suppl 3):S117-22.
    170. Morgan, SL, Abercrombie, W, Lee, JY. Need for precision studies at individual institutions and assessments of size of regions of interest on serial DXA scans. J Clin Densitom. 2003; 6(2):97-101.
    171. Lin, L, Kaplan, L, Lee, J, Chadburn, A, Cesarman, E, Herman, JG, Ambinder, RF, And the AIDS Malignancy Consortium. Monitoring Epstein-Barr virus Load in Periperal Blood in AIDS-related Lymphoma Patients: An AIDS Malignancy Consortium Laboratory Study. 2002.
    172. Noy, A, Gill, P, Scadden, D, Lee, J, Dezube, B, Aboulafia, D, Tulpule, A, Walmsley, S, For the AIDS malignancy Consortium and IM862 Team. Angiogenesis Inhibitor IM862 is Ineffective against AIDS-KS in a Randomized, Placebo Controlled Trial. 2002.
    173. Miles SA, Dezube BJ, Lee JY, Krown SE, Fletcher MA, Saville MW, Kaplan L, Groopman J, Scadden DT, Cooley T, Von Roenn J, Friedman-Kien A. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma. AIDS. 2002 Feb 15; 16(3):421-9. PMID: 11834954.
      View in: PubMed
    174. Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Scadden DT, Ratner L, Pluda JM, Figg WD, Krown SE, Dezube BJ. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol. 2002 Jan 01; 20(1):153-9. PMID: 11773164.
      View in: PubMed
    175. Miles, SA, Dezube, BJ, Lee, JY, Fletcher, MA, Saville, MW, Kaplan, LD, Groopman, J, Scadden, DT, Cooley, T, Krown, SE, Von Roenn, J, Friedman-Kien, A. For the AIDS Malignancy Consortium. Anti-tumor activity of oral 9-cis retinoic acid in HIV-infected patients with Kaposi's sarcoma: a multicenter trial of the AIDS Malignancy Consortium. AIDS. 2002; 16421-429.
    176. Eubanks, V, Koppersmith, N, Wooldridge, N, Clancy, JP, Lyrene, R, Arani, RB, Lee, J, Moldawer, L, Atchison, J, Sorscher, EJ, Makris, CM. Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis. J Pediatr. 2002; 140(4):439-444.
    177. Rex, JH, Ostrosky-Zeichner, L, Pappas, PG, Hamill, RJ, Larsen, RA, Horowitz, H, Powderly, WG, Hyslop, N, Kauffman, CA, Chapman, SW, Mangino, J, Lee, J, For the NIAID-MSG Candidiasis Subproject. Antifungal Susceptibility Survey of 2000 Bloodstream Candida Isolates from the United States. 2002.
    178. Woodberry, T, Henry, L, O'Connor, P, Davis, J, Lee, J, Kaplan, L, Khayrallah, M, Osmond, D, Martin, J, Scadden, D, Brander, C, And the AIDS Malignancy Consortium. Mediated immune response to KSHV ORF65 and ORF73 in individuals with and without KS. 2002.
    179. Walsh, TJ, Pappas, PG, Winston, D, Lazurus, HM, Petersen, F, Raffalli, J, Yanovich, S, Stiff, P, Greenberg, R, Donowitz, G, Lee J, For the NIAID Mycoses Study Group, Lee. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy in persistently febrile neutropenic patients: a prospective, randomized, multicenter, international trial. N Engl J Med. 2002; 346(4):225-234.
    180. Rex, JH, Pappas, PG, Karchmer, AW, Sobel, J, Edwards, J, Brass, C, Chapman, S, Horowitz, H, Zervos, M, McKinsey, D, Kett, D, Simmons, B, Lee, J, Mautner, L, Chu, TC, Panzer, H, And the Candidemia Study Group. A Randomized & Blinded Multicenter Trial od High-Dose Fluconazole (F) + Placebo (P) vs. F + Amphotericin B (A) as Treatment of Candidemia in Non-Neutropenic Patients. 2001.
    181. Ostrosky-Zeichner, L, Rex, JH, Pappas, PG, Hamill, RJ, Larsen, RA, Horowitz, H, Powderly, WG, Hyslop, N, Kauffman, CA, Chapman, SW, Mangino, J, Lee, J, For the NIAID-MSG Candidiasis Subproject. Three Year Survey of Regional and Temporal Trends in Fluconazole (FLU) Resistance (R) Among Bloodstream Candida spp. Isolates from the United States. 2001.
    182. Ratner, L, Lee, J, Tang, S, Redden, D, Hamzeh, F, Herndier, B, Scadden, D, Kaplan, L, Ambinder, R, Levine, A, Harrington, W, Grochow, L, Flexner, C, Tan, B, Straus, D. For the AIDS Malignancy Consortium. Chemotherapy for HIV-associated non-Hodgkin's Lymphoma in Combination with Highly Active Antiretroviral Therapy. J Clin Oncol. 2001; 19(8):2165-2170.
    183. Perfect, JR, Cox, GM, Lee, JY, Kauffman, CA, De Repentigny, L, Chapman, SW, Morrison, VA, Pappas, P, Hiemenz, JW, Stevens, DA, And the NIAID-sponsored Mycoses Study Group. The impact of culture isolation of aspergillus: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001; 33:1824-33.
    184. Kim, JR, Oberman, A, Fletcher, GF, Lee, JY. Effect of exercise intensity and frequency on lipid levels in men with coronary heart disease: Training Level Comparison Trial. Am J Cardiol. 2001; 87(8):942-946.
    185. Walsh, T, Pappas, P, Winston, D, Blumer, J, Peterson, F, Yanovich, S, Raffalli, J, Stiff, P, Greenberg, R, Donowitz, G, Schuster, M, Arndt, C, Reinhardt, J, Reboli, A, Anaissie, E, Hadley, S, Garber, G, Wingard, J, Floritoni, G, Lee, J, And the NIAID Mycoses Study Group. Voriconazole versus Liposomal Amphotericin B for empirical antifungal therapy of persistently febrile neutropenic patients: a ramdomized, international, multicenter trial. 2000.
    186. Cianfrocca, M, Cooley, TP, Lee, J, Scadden, DT, Ratner, L, Dezube, BJ. Angiogenesis inhibitor Col-3 in the treatment of HIV-related Kaposi's Sarcoma: a phase I AIDS Malignancy Consortium Study. 2000.
    187. Stevens, DA, Schwartz, HJ, Lee, JY, Moskovitz, BL, Jerome, DC, Catanzaro, A, Bamberger, DM, Weinmann, AJ, Tuazon, CU, Judson, MA, Platts-Mill, TAE, DeGraff, AC Jr. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000; 342:756-62.
    188. Kauffman, CA, Vazquez, JA, Sobel, JD, Gallis, HA, McKinsey, DA, Karchmer, AW, Sugar, AM, Sharkey, PK, Wise, GJ, Mangi, R, Mosher, A, Lee JY, Dismukes, WE. A prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis. 2000; 30:14-18.
    189. Sobel, JD, Kauffman, CA, McKinsey, D, Zervos, M, Vazquez, JA, Karchmer, AW, Lee J, Thomas, C. Candiduria - A randomized, double blind study of treatment with fluconazole and placebo. Clin Infect Dis. 2000; 30:19-24.
    190. Cox, GM, Perfect, JF, Stevens, DA, Kauffman, CA, Lee, JY, And the NIAID Mycoses Study Group. Hospital-based Survey of Aspergillosis. 1999.
    191. O'Sullivan CE, Drew WL, McMullen DJ, Miner R, Lee JY, Kaslow RA, Lazar JG, Saag MS. Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy. J Infect Dis. 1999; 180(3):847 - 849.
    192. Saag, MS, Fessel, WJ, Kaufman, C, Merrill, KW, Ward, DJ, Moskovitz, BL, Thomas, C, Oleka, N, Guarnieri, JA, Lee, J, Brenner-Gati, L, Klausner, M. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients. AIDS Res Hum Retroviruses. 1999; 15(16):1413-1417.
    193. Schwartz, HJ, Stevens, DA, Lee, JY, Jerome, D, Catanzaro, A, And the NIAID Mycoses Study Group. A randomized double blind study of itraconazole (IZ) in allergic bronchopulmonary aspergillosis (ABPA): open label phase. 1999.
    194. Pappas, PG, Rex, JH, Lee, J, Hamill, R, Larsen, R, Powderly, W, Horowitz, H, Hyslop, N, Mangino, J, Webster, R, Thomas, C, And the NIAID Mycoses Study Group Candidiasis Subproject. Candidemia in the United States: Therapeutic Approaches and the Emergence of Non-albicans Candida species. 1998.
    195. Julian BA, Brantley RR, Barker CV, Stopka T, Gaston RS, Curtis JJ, Lee JY, Prchal JT. Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis. J Am Soc Nephrol. 1998; 9(6):1104 - 1108.
    196. Lee, J, Miles, S, Friedman-Kien, A, For the NCI AIDS Malignancies Consortium. Suspending Enrollment in a Two-Stage Phase II AIDS Malignancies Consortium Trial of AIDS Kaposi's Sarcoma Patients. 1998.
    197. Miles, SA, Dezube, B, Lee, J, Groopman, J, Saville, W, Scadden, D, Debruge, J, Friedman-Kien, And the AMC 002 Team. Oral LGD1057 is Active in AIDS Related Kaposi's Sarcoma: An AIDS Malignancies Consortium Trial (AMC-002). 1998.
    198. Thomas CJ, Lee JY, Conn LA, Bradley ME, Gillespie RW, Dill SR, Pinner RW, Pappas PG. Surveillance of cryptococcosis in Alabama, 1992-1994. Ann Epidemiol. 1998; 8(4):212 - 216.
    199. Lee, J, Miles, SA, Dezube, B, Kaplan, L, Groopman, J, Saville, W, Scadden, D, Debruge, J, Friedman-Kien, A, And the AMC 002 Team. Recruitment in a Two-Stage Phase II Trial of AIDS Kaposi's Sarcoma. 1998.
    200. Friedman-Kien, A, Dezube, B, Lee, JY, Groopman, J, Saville, W, Scadden, D, Debruge, J, Miles, S, And AMC 002 Team. Oral 9-cis Retinoic Acid is Active in AIDS Related Kaposi's Sarcoma: AIDS Associated Malignancy Consortium Study 002. 1998.
    201. El GT, Sobol W, Wadlington VR, Sillers MJ, Crews C, Fisher WS, Lee JY. Cerebrospinal fluid fistula: detection with MR cisternography. AJNR Am J Neuroradiol. 1998; 19(4):627 - 631.
    202. Morgan SL, Baggott JE, Lee JY, Alarcon GS. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol. 1998; 25(3):441 - 446.
    203. Ayar D, Golla B, Lee JY, Nath H. Needle-track metastasis after transthoracic needle biopsy. J Thorac Imaging. 1998; 13(1):2 - 6.
    204. Kilby, JM, Hopkins, S, Venetta, TM, DiMassimo, B, Cloud, GA, Lee, JY, Alldredge, L, Hunter, E, Lambert, D, Bolognesi, D, Matthews, T, Johnson, MR, Nowak, MA, Shaw, GM, Saag, MS. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat med. 1998; 4(11):1302-7.
    205. Sobel, JD, McKinsey, D, Kauffman, C, Zervos, M, Vazquez, JA, Lee, J. Asymptomatic candiduria: A randomized double blind study of treatment with fluconazole and placebo. 1997.
    206. Sobel, JD, McKinsey, D, Kauffman, C, Zervos, M, Vazquez, JA, Lee, J. Asymptomatic candiduria: A randomized double blind study of treatment with fluconazole and placebo. Proceedings of the Infectious Diseases. 1997; 73.
    207. Pappas, PG, Rex, JH, Hamill, RJ, Larsen, RA, Powderly, WG, Horowitz, H, Kauffman, CA, Chapman, SW, Lee, J. Current trends in nosocomial candidemia: results of a large multicenter study. 1997.
    208. Figueroa-Colon R, Franklin FA, Lee JY, Aldridge R, Alexander L. Prevalence of obesity with increased blood pressure in elementary school-aged children. South Med J. 1997; 90(8):806 - 813.
    209. Lee, J, Mosher, A, Gallis, H, Panzer, H, Sobel, J. Comparison of Participants and non-participants in a clinical trial of funguria. 1997.
    210. Stevens, D, Lee, J. Analysis of compassionate use itraconazole of invasive aspergillosis by the NIAID Mycoses Study Group criteria. 1997.
    211. Pappas, PG, Rex, JH, Hamill, RJ, Larsen, RA, Powderly, WG, Horowitz, H, Kauffman, CA, Chapman, SW, Lee, J. Current trends in nosocomial candidemia: results of a large multicenter study. Proceedings of the Infectious Diseases Society of America 35th meeting. 1997; 73.
    212. Knoll, GA, Tankersley, MR, Lee, JY, Julian, BA, Curtis, JJ. The impact of renal transplantation on survival in Hepatitis C positive end-stage renal disease patients. Am J Kidney Dis. 1997; 29(4):608-14.
    213. Stevens, DA, Lee JY. Analysis of compassionate use itraconazole therapy of invasive aspergillosis by the NIAID Mycoses Study Group. Arch Intern Med. 1997; 157:1857-1862.
    214. Meredith, RF, Salter, MM, Kim, RY, Spencer, SA, Weppelmann, B, Rodu, B, Smith, JW, Lee JY. A randomized trial evaluation of sucralfate for radiation mucositis. Int J Radiat Oncol Biol Phys. 1997; 37(2):275-279.
    215. Lee, J, Mosher, A, Gallis, H, Panzer, H, Sobel, J. Comparison of participants and non-participants in a clinical trial of funguria. Control Clin Trials. 1997; 121S.
    216. Mulligan, SA, Bostany, CA, Lee, JY. Impact of double reading mammography in private practice setting. 1996.
    217. Figueroa-Colon R, Franklin FA, Goran MI, Lee JY, Weinsier RL. Reproducibility of measurement of resting energy expenditure in prepubertal girls. Am J Clin Nutr. 1996; 64(4):533 - 536.
    218. Figueroa-Colon R, Franklin FA, Lee JY, Von Almen TK, Suskind RM. Feasibility of a clinic-based hypocaloric dietary intervention implemented in a school setting for obese children. Obes Res. 1996; 4(5):419 - 429.
    219. Kusek, JW, Lee, JY, Greene, PG, Douglas, M, Grim, C, Kirk, KA, Milligan, S, Smith, DE, Whelton, PK, Agodoa, LY. Appointment attendance, pill counts and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension (AASK) pilot study. 1996.
    220. Kusek, JW, Lee, JY, Smith, DE, Milligan, S, Faulkner, M, Cornell, C, Kopple, JD, Greene, PG, Agodoa, LY. Quality of Life among clinical trial screens during baseline in the African American Study of Kidney Disease and hypertension (AASK) pilot Study. 1996.
    221. Lee, JY, Greene, PG, Douglas, M, Grim, C, Kirk, KA, Milligan, S, Smith, DE, Whelton, PK. Appointment attendance, pill counts and achievement of target blood pressure in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996; 17:17S-33S.
    222. Kusek, JW, Lee, JY, Charleston, J, Faulkner, M, Levell, B, Milligan, S, Norris, K. Participant satisfaction in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996; 17:47S-54S.
    223. Oberman, A, Fletcher, GF, Lee J, Nanda, N, Fletcher, BJ, Jensen, BE, Caldwell, ES. Efficacy of high intensity exercise training on left ventricular ejection fraction in men with coronary heart disease: the Training Levels Comparison Study. Am J Cardiol. 1996; 76(10):643-7.
    224. Wright, JT Jr, Kirk, KA, Kusek, JW, Toto, R, Lee, JY, Agodoa, LY, Randall, OS, Glassock, R. Design of the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996; 17:3S-16S.
    225. Lee, JY, Rhode, CA. Likelihood techniques for discrete distributions. 136th Annual Meeting of the American Statistical Association. 1996; 96.
    226. Lee, J, Bernhard, S, Douglas, M, Greene, P, Kusek, J, Norris, K, Whelton, P. Assessing medication adherence in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens. 1996; 9:719-725.
    227. Jensen, BE, Fletcher, BJ, Rupp, JC, Fletcher, GF, Lee JY, Oberman, AL. Training level comparison study: Effect of high and low intensity exercise on ventilatory threshold in men with coronary artery disease. J Cardiopulm Rehabil. 1996; 16(4):227-32.
    228. Kusek, JW, Lee, JY, Smith, DE, Milligan, S, Faulkner, M, Cornell, CM, Kopple, J, Greene, PG. Effect of blood pressure control and antihypertensive drug regimen on quality of life: the African American Study of Kidney Disease and Hpertension (AASK) Pilot Study. Control Clin Trials. 1996; 17:40S-46S.
    229. Knoll, GA, Tankersly, MR, Lee, JY, Julian, BA, Curtis, JJ. Renal transplantation improves survival of anti-HCV positive ESRD patients. 1996.
    230. Whelton, PK, Lee, JY, Kusek, JW, Charleston, J, Debruge, J, Douglas, M, Faulkner, M, Greene, P, Jones, C, Kiefer, S, Kirk, KA, Levell, B, Norris, K, Powers, S, Retta, TM, Smith, DE, Ward, H. Recruitment in the African American Study of Kidney Disease and Hypertension. Control Clin Trials. 1996; 17:34S-39S.
    231. Lee, JY, Smith, DE, Cornell, CE, Faulkner, M, Kopple, J, Kusek, JW, Milligan, S. Quality of life in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. 1995.
    232. Gallis, H, Sobel, J, Kauffman, C, Karchmer, A, McKinsey, D, Mosher, A, Lee, J. A prospective multicenter surveillance study of funguria in hospitalized patients. 1995.
    233. Meredith, R, Salter, M, Kim, R, Spencer, S, Weppelmann, B, Rodu, B, Smith, J, Lee, J. Sucralfate for radiation mucositis: results of a double-blind randomized trial. 1995.
    234. Figueroa-Colon, R, Franklin, FA, Goran, MI, Lee, JY, Aldridge, R, Weinsier, RL. Reproducibility of resting energy expenditure (REF) in prepubertal females. 1995.
    235. Fletcher, GF, Oberman, A, Fletcher, BJ, Dunbar, SB, Lee, J, Rice, CR. Training Level Comparison Study: Effects of exercise training intensity on insulin and glucose levels in coronary patients with "clustering" of risk factors. 1995.
    236. Figueroa-Colon, R, Franklin, FA, Lee, J, Aldridge, R, Alexander, L. Obesity with increased blood pressure is progressive and prevalent in elementary school-age children. 1995.
    237. Weinsier, R, Wilson, LJ, Lee, JY. Medically safe rate of weight loss: a guideline based on the currently available data. Am J Med. 1995; 98(2):115-7.
    238. Whelton, P, Lee, J, Kopple, J, Kusek, J, Faulkner, J, Charleston, J. Challenge of minority recruitment in clinical trials: experience of the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. 1995.
    239. Whelton, P, Lee, J, Kopple J, Kusek, J, Faulkner, J, Charleston, J. Challenge of minority recruitment in clinical trials: experience of the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1995; 43S.
    240. Lee, J, Bernard, S, Douglas, M, Greene, P, Kusek, J, Norris, K, Whelton, P. Assessing medication adherence in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. 1995.
    241. Lee, J, Bernhard, S, Douglas, M, Greene, P, Kusek, J, Norris, K, Whelton, P. Assessing medication adherence in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1995; 37S.
    242. Kusek, J, Lee, J, Charleston, J, Faulkner, M, Levell, B, Milligan, S, Norris, K. Reasons for joining and barriers to participation in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1995; 42S.
    243. Kusek, J, Lee, J, Charleston, J, Faulkner, M, Levell, B, Milligan, S, Norris, K. Reasons for joining and barriers to participation in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. 1995.
    244. Figueroa-Colon, R, Lee, J, Aldridge, R, Alexander, L. Obesity is Prevalent and Progressive in Birmingham School Children. 1994.
    245. Raczynski, JM, Oberman, A, Fletcher, GF, Lee, JY, Fletcher, BJ. Training Levels Compairson Study: Psychological Effects of Different Exercise Intensities in Coronary Artery Disease Patients. 1994.
    246. Lee, JY. Patterns of short-term adherence in the African American Study of Kidney Disease and Hypertension. 1994.
    247. Morgan, SL, Baggott, JE, Vaughn, WH, Austin, JS, Veitch, TA, Lee, JY, Koopman, WJ, Krumdieck, CL, Alarcon, GS. Supplementation with folic acid during methotrexate therapy of rheumatoid arthritis: results from a double-blind, placebo-controlled trial. Ann Intern Med. 1994; 121(11):833-841.
    248. Whelton, P, Kusek, J, Lee, J, Faulkner, M. Recruitment in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol. 1994; 570.
    249. Lee JY. Uses of clinical databases. Am J Med Sci. 1994; 308:58-62.
    250. Whelton, P, Kusek, J, Lee, J, Faulkner, M. Recruitment in the African American Study of Kidney Disease and Hypertension. 1994.
    251. Denning, DW, Lee JY, Hostetler, JS, Pappas, P, Kauffman, CA, Dewsnup, DH, Galgiani, JN, Graybill, JR, Sugar, AM, Catanzaro, A, Gallis, H, Perfect, JR, Dockery, B, Dismukes, WE, Stevens, DA. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy of invasive aspergillosis. Am J Med Sci. 1994; 308:58-62.
    252. Kusek, JW, Lee, JY, Agodoa, LY, Kirk, KA, Wright, JT, Glassock, R. Study design of the pilot phase of the African American Study of Kidney Disease and Hypertension (AASK). Control Clin Trials. 1994; 1335.
    253. Jensen, B, Fletcher, B, Rupp, J, Fletcher, G, Lee J. Training Levels Comparison Study: effect of high and low intensity exercise on ventilatory threshold in men with coronary artery disease. 1993.
    254. Perry, G, Kell, S, Lee, J, Oberman, A. Endurance exercise training improves cardiovascular performance in healthy older women. 1993.
    255. Oberman, A, Fletcher, GF, Lee, JY, Barbara, BJ, Jensen, BE. Training Level Comparison Study (TLC): one-year blood pressure findings. 1993.
    256. Fletcher, GF, Oberman, A, Nanda, NC, Fletcher, BJ, Lee, JY, Dunbar, SB. Training Levels Comparison Study: effects of high and low level exercise training on left ventricular ejection fraction in subjects with coronary artery disease. 1993.
    257. Sweeney, ME, Fletcher, GF, Oberman, A, Nanda, N, Clements, SD, Fletcher, BJ, Dunbar, SB, Lee, JY. Training Levels Comparison Study: comparison of two exercise echocardiograph methods for determining left ventricular ejection fraction. 1993.
    258. Robert, F, Mignucci, M, McCurdy, SA, Maldonado, N, Lee JY. Hemostatic abnormalities associated with monoclonal gammopathics. Am J Med Sci. 1993; 306(6):359-366.
    259. Modell, JG, Taylor, JP, Lee JY. Breath-alcohol values following mouthwash use: is it safe to swish and drive?. JAMA. 1993; 270:2955-2956.
    260. Modell, JG, Mountz, JM, Glaser, FB, Lee JY. Effect of haloperidol on measures of craving and impaired comtrol in alcoholic subjects. Alcoholism. 1993; 17(2):234-40.
    261. Soong SJ, Shaw HM, Balch CM, McCarthy WH, Urist MM, Lee JY. Predicting survival and recurrence in localized melanoma: a multivariate approach. World J Surg. 1992; 16(2):191 - 195.
    262. Harmon, BH, Berland, LL, Lee, JY. Effect of varying rates of low-osmolarity contrast media injection for hepatic CT: correlation with indocyanine green transit time. Radiology. 1992; 184(2):379-82.
    263. Weinsier, R, Lee J, Darnell, B. Comparison of physiologic extremes of high and low carbohydrate diets on fuel utilization and energy expenditure. Am J Clin Nutr. 1992; 55(3 Suppl):97.
    264. Ruckdeschel JC, Moores D, Lee JY, Einhorn LH, Mandelbaum I, Koeller J, Weiss GR, Losada M, Keller JH. Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest. 1991; 100(6):1528 - 1535.
    265. Jansen, B, Lee, J, Nanda, N, Fletcher, B, Oberman, A, Fletcher, G. Training level comparison study: decreased left ventricular fraction improves with exercise training in patients with coronary artery disease. 1991.
    266. Dunbar, S, Fletcher, B, Jensen, B, Raczynski, J, Lee, J, Oberman, A, Fletcher, G. Training level comparison study: predictive factors associated with exercise compliance. 1991.
    267. Denning, DW, Pappas, PG, Kauffman, CA, Hostetler, JS, Lee, JY, Stevens, DA, And the NIAID Mycoses Study Group. Oral itraconazole therapy of invasive aspergillosis. 1991.
    268. Saleh MN, Wheeler RH, Lee JY, Khazaeli MB, Unger MW, Russell CH, LoBuglio AF. In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomas. Clin Nucl Med. 1991; 16(2):110 - 116.
    269. Johnson, DH, Ruckdeschel, JC, Keller, JH, Lyman, GH, Kallas, GJ, Macdonald, J, DeConti, RC, Lee J. A randomized trial to compare intravenous and orally-administered etoposide in combination with cisplatin for the treatment of small cell cancer. Cancer. 1991; 67(1 Supp):245-249.
    270. Mulligan, SA, Matsuda, T, Lanzer, P, Gross, GM, Routh, WD, Keller, FS, Koslin, DB, Berland, LL, Fields, MD, Doyle, M, Cranney, G, Lee J, Pohost, G. Prospective comparison of MR angiography and colon duplex ultrasound with conventional angiography for peripheral arterial occlusive disease. Radiology. 1991; 178(3):695-700.
    271. Kim RY, Spencer SA, Meredith RF, Weppelmann B, Lee JY, Smith JW, Salter MM. Extradural spinal cord compression: analysis of factors determining functional prognosis--prospective study. Radiology. 1990; 176(1):279 - 282.
    272. Ruckdeschel, J, Moores, D, Lee, J, Einhorn, L, Mandelbaum, I, Koeller, J, Weiss, G, Losada, M, Keller, J. Management of malignant pleural effusions (MPE): a randomized comparison of tetracycline and bleomycin. 1990.
    273. Moores, DWO, Ruckdeschel, JC, Lee, JY, Einhorn, LH, Mandelbaum, I, McKneally, MF. Intrapleural bleomycin vs. tetracycline in the management of malignant pleural effusion. 1990.
    274. Saleh, M, Khazaeli, M, Wheeler, R, Rogers, K, Lee, J, LoBuglio, AF. Phase II trial of MoAb 17-1A and y-INF in the treatment of metastatic colon cancer. 1990.
    275. Sheffield, LT, Oberman, O, Fletcher, G, Nanda, N, Fletcher, B, Sulentic, J, Thiel, J, Lee, J. Training levels comparison study: response to treadmill and left lateral recumbent cycle exercise in men with coronary heart disease. 1990.
    276. Lee, J, Oberman, A, Fletcher, G, Sulentic, J. Training levels comparison (TLC) Trial design issues. 1990.
    277. Raczynski, JM, Oberman, A, Fletcher, GF, Lee, JY, Fletcher, BJ. Training level comparison study - psychological effects of different exercise intensities in coronary artery disease patients. 1990.
    278. Lee JY, Soong SJ. Cancer mortality in the South, 1950 to 1980. South Med J. 1990; 83(2):185 - 190.
    279. Saleh MN, LoBuglio AF, Wheeler RH, Rogers KJ, Haynes A, Lee JY, Khazaeli MB. A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological data. Cancer Immunol Immunother. 1990; 32(3):185 - 190.
    280. Dismukes, WE, Wade, JS, Lee JY, Dockery, BK, Hain, JD. Nystatin therapy of candidiasis hypersensitivity syndrome: results of a prospective, randomized clinical trial. N Engl J Med. 1990; 323(25):1717-1723.
    281. Trotti, A, Weppelman, B, Kim, R, Lee J, Salter, M. Results of custom surface applicators in cancers of the oral cavity and oropharynx. Endocurie Hyperthermia. 1990; 6:143-151.
    282. Fletcher, GF, Oberman, A, Sheffield, LT, Lee, JY, Fletcher, BJ, Felner, JM, Nanda, NC, Jensen, BE, Sulentic, JA. Training level comparison study: influence of left ventricular function on maximal exercise test duration and maximal oxygen comsumption. 1989.
    283. Sulentic, J, Dunnam, L, Thiel, J, Fletcher, B, Oberman, A, Fletcher, G, Sheffield, T, Lee, J. Training level comparison study: factors influencing exercise compliance. 1989.
    284. Oberman, A, Fan, P-H, Nanda, NC, Lee JY, Huster, WJ, Sulentic, JA, Storey, OF. Reproducibility of two-dimensional exercise echocardiography. J Am Coll Cardiol. 1989; 14:923-928.
    285. Ryan, WG, Richards, JM, Lee JY. Characteristics of the in vivo RBC: Plasma lithium ratio in a clinical setting. Biol Psychiatry. 1989; 26:537-540.
    286. Saleh, MN, Moore, DL, Lee JY, LoBuglio, AF. Monocyte-platelet interaction in immune and non-immune thrombocytopenia. Blood. 1989; 74(4):1328-1331.
    287. Wade, JS, Dockery, BK, Lee, JY, Dismukes, WE. Nystatin therapy for candida hypersensitivity syndrome. 1988.
    288. LoBuglio, AF, Saleh, M, Lee J, Khazaeli, MB, Carrano, R, Holden, H, Wheeler, R. Phase I Trial of repetitive large doses of murine monoclonal antibody 17-1A I Clinical Aspects. J Natl Cancer Inst. 1988; 80:932-936.
    289. Silvey, L, Carpenter, JT, Wheeler, RH, Lee J, Conolley, C. A randomized comparison of halperidol plus dexamethothasone versus prochlorperazine plus dexamethothasone in preventing nausea and vomiting in patients receiving chemotherapy in breast cancer. J Clin Oncol. 1988; 6:1397-1400.
    290. Berland, LL, Lee, JY. Comparison of contrast media injection rates and volumes for hepatic dynamic incremented CT. Invest Radiol. 1988; 23:918-922.
    291. Lee, JY, Soong, S-j. An overview of Alabama cancer mortality among whites: 1950-1980. Ala J Med Sci. 1988; 25:375-382.
    292. Berland, LL, Koslin, DB, Kenney, PJ, Stanley, RJ, Lee, JY. Differentiation of benign from malignant adrenal masses using dynamic contrast enhanced CT criteria. AJR Am J Roentgenol. 1988; 151:95-102.
    293. LoBuglio, AF, Wheeler, R, Leavitt, RD, Harvey, EB, Holden, HT, Haynes, A, Rogers, K, Lee, J, Khazaeli, M. Pharmacokinetics and immune response to chimeric mouse/human monoclonal antibody (Ch-17-1A) in man. Proceedings of the 1988 meeting of the American Society of Clinical Oncology. 1988; 1111.
    294. LoBuglio, AF, Khazaeli, MB, Lee, J, Haynes, A, Sumerel, L, Mischak, R, Spitler, L. Pharmacokinetics and immune response to xomazyme - mel in melanoma patients. Antibody, Immunoconjugates, and Radiopharmaceuticals. 1988; 1(1):305-310.
    295. Lee, JY, White, JM. %SURVCOMP - SAS %MACRO for desctiptive survival analysis. Proceedings of the 1985 Meeting of the SAS User's Group International. 1985.
    296. Thomas PR, Lee JY, Fineberg BB, Razek AA, Perez CA, Land VJ, Vietti TJ. An analysis of neuroblastoma at a single institution. Cancer. 1984; 53(10):2079 - 2082.
    297. Manu P, Runge LA, Lee JY, Oppenheim AD. Judged frequency of complications after invasive diagnostic procedures. Systematic biases of a physician population. Med Care. 1984; 22(4):366 - 370.
    298. Fondy, EM, Lee, JY. SEQRAN - An interactive sequential randomization system for clinical trials. Proceedings of the SAS user's Group International. 1984; 775-780.
    299. Mill, WB, Baglan, RJ, Kurichety, P, Prasad, S, Lee, JY, Moller, R. Symptomatic radiation-induced pericarditis in Hodgkin's disease. Int J Radiat oncol Biol Phys. 1984; 10:2061-2065.
    300. Manu, P, Runge, LA, Lee, JY, Oppenheim, AD. Perceived frequency of serious complications after "invasive" diagnostic procedures: Systematic biases of a physician population. 1983; 300A.
    301. Lee, JY, Breaux, SR. Accrual of radiation therapy patients to clinical trials. Cancer. 1983; 52:1014-1016.
    302. Lee JY, Marks JE, Simpson JR. Age as a criterion for eligibility in a lung cancer clinical trial. Am J Clin Oncol. 1982; 5(4):449 - 452.
    303. Lee JY, Bedwinek JM, Fineberg BB, Ocwieza MA. Alternative approaches to evaluating the impact of local control on survival. Am J Clin Oncol. 1982; 5(3):281 - 284.
    304. Lee JY. A statistical note: selection of an endpoint. Am J Clin Oncol. 1982; 5(3):261 - 265.
    305. Bedwinek, J, Rao, DV, Perez, C, Lee, J, Fineberg, B. Stage III and localized stage IV breast cancer: Irradiation alone versus irradiation plus surgery. Int J Radiat Oncol Biol Phys. 1982; 8:31-36.
    306. Lee, JY, Perez, CA, Ettinger, N, Fineberg, BB. The risk of second primaries subsequent to irradiation for cervix cancer. Int J Radiat Oncol Biol Phys. 1982; 8:207-211.
    307. Rao, DV, Bedwinek, JM, Perez, CA, Lee, JY, Fineberg, BB. Stage III carcinoma of the breast: Analysis of prognostic factors. Cancer. 1982; 50:2037-2043.
    308. Lee, JY, Perez, CA. A radiation oncology oriented anatomico-pathological classification system. Int J Radiat Oncol Biol Phys. 1981; 7:813-815.
    309. Bedwinek, JM, Lee, JY, Fineberg, BB, Ocwieza, MA. Prognosis indicators in patients with isolated local-regional recurrence of breast cancer. Cancer. 1981; 47:2232-2235.
    310. Bedwinek, JM, Fineberg, BB, Lee, JY, Ocwieza, MA. Analysis of failures following radiotherapy for isolated local-regional recurrence of breast cancer. Int J Radiat Oncol Biol Phys. 1981; 7:581-585.
    311. Kurichety, PR, Mill, WB, Prasad, SC, Lee, JY. Radiation induced pericarditis in mantle irradiation: Analysis of causative factors. 1980; 1366.
    312. Lee JY, Marks JE, Simpson JR. Recruitment of patients to cooperative group clinical trials. Cancer Clin Trials. 1980; 3(4):381 - 384.
    313. Kumar, S, Lee, JY, Hernandez, A, Crawford, C, Goldring, D. Baroreceptor function in juvenile primary hypertension. 1980; 429.
    314. Meyer, JS, Lee JY. Relationships of S-phase fraction of breast carcinoma in relapse to remission-duration, estrogen receptor contents, therapeutic responsiveness and duration of survival. Cancer Res. 1980; 40:1890-95.
    315. Martin, SA, Marks, JE, Lee, JY, Bauer, WC, Ogura, JH. Carcinoma of the pyriform sinus: Predictors of TNM relapse. Cancer. 1980; 46:1974-81.
    316. Lee JY. An Interactive System for Clinical Trials. Proceedings of the Third Annual Symposium on Computer Applications in Medical Care. 1979; 404-405.
    317. Goldring D, Hernandez A, Choi S, Lee JY, Londe S, Lindgren FT, Burton RM. Blood pressure in a high school population. II. Clinical profile of the juvenile hypertensive. J Pediatr. 1979; 95(2):298 - 304.
    318. Lee JY. Evaluation of phase I trial data using likelihood techniques. Summaries of papers presented at the Joint Statistical meeting of the American Statistical Association, Biometrics Society, and Institute for Mathematical Statistics. 1978.
    319. Juhlin KD, Lee JY, Ragan DP. A MUMPS based survival analysis package. 1977; 61-64.
    320. Ortbals DW, Liebhaber H, Presant CA, Van AA, Lee JY. Influenza immunization of adult patients with malignant diseases. Ann Intern Med. 1977; 87(5):552 - 557.
    321. Perez CA, Reeves GI, Glasgow G, Lee JY. The role of the radiation therapy in the local and regional control of carcinoma of the breast. Int J Radiat Oncol Biol Phys 2 (Suppl 2). 1977; 99.
    322. Perez CA, Braun L, Lee JY. Psychological reactions of patients to radiation therapy and the diagnosis of cancer. Int J Radiat Oncol Biol Phys2 (Suppl2). 1977; 128.
    Lee's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _